Languages Available
 
C

PT. Indofarma (Persero) Tbk [INAF]   IDR 4.200  +90 (2,19%)


Loading...
INAF IDR 4.200  +90 (2,19%)
Last Update 17 October 2018 04:00 PM
Open
IDR 4.110
Prev Close
IDR 4.110
Offer
IDR 4.220
Bid
IDR 4.200
Day Low
IDR 4.110
Day High
IDR 4.210
Volume
318 Lots (31.800 Shares)
Transaction Value (IDR)
133,36 M
Frequency
51 (Times)
EPS (IDR)
0,16
PE Ratio (ttm)
25.712,90 Times
Market Cap. (IDR)
13.015.800,00 M
Market Cap. Rank in Industry
#3 of 11 Companies in Pharmaceuticals
Market Cap. Rank in All Companies
#77 of 632 Companies
F
Net Foreign

This section of IDNFinancials requires you to sign up as a premium member of IDNFinancials.

Please check our pricing page to see all of our features.
O
Overview


PT. Indofarma (Persero) Tbk (INAF) is a manufacturer of drug, which consists of several product categories, namely Unbranded Generic or OTC Over the Counter (OTC), branded generic, rapid diagnostic test, and others. In addition, it also produces packaging materials, machinery, equipment and infrastructure related to pharmaceutical and other industries. The company commenced its commercial operations and production on 1983. The company’s products are marketed both domestically and internationally.

Subsidiary Affiliation
 
Company Name
Percentage
1.
PT. Indofarma Global Medika
99,99 %
I
IPO
IPO Date17 April 2001
Offering Shares596.875.000
Company Listing2.500.000.000
Total List Shares3.096.875.000
Percentage19,27 %
Offering PriceRp 250
Fund RaisedRp 149.218.750.000
Securities Administration BureauPT. Datindo Entrycom
Lead UnderwriterPT. Bahana Securities
Listing BoardMain
No IPO bonds found
No IPO rights issue found
D
Dividend

This section of IDNFinancials requires you to sign up as a premium member of IDNFinancials.

Please check our pricing page to see all of our features.
G
Management
Commissioners
-
President Commissioner
Siswanto
Commissioner
Nizar Yamanie
Independent Commissioner
Teddy Wibisana
Directors
-
President Director
Rusdi Rosman
Director
Eko Dodi Santosa
Director
Herry Triyatno
Graph goes here...
S
Shareholders
No. Shareholder Name Number of Shares Total Paidup Capital Percentage
1. (Serie B) - Goverment of The Republic of Indonesia 2.499.999.999 IDR 249.999.999.900 80,66 %
2. (Serie B) - Public (each below 5%) 399.271.000 IDR 39.927.100.000 12,88 %
3. (Serie B) - PT. ASABRI (Persero) 199.996.500 IDR 19.999.650.000 6,45 %
4. (Serie A) - Goverment of The Republic of Indonesia (Dwiwarna) 1 IDR 100 0,00 %
V
Videos
IDNFinancials Video - Company profile PT Indofarma Tbk
10 January 2013 09:02 AM
Company profile PT Indofarma Tbk
S
News Update
20 July 2018 03:39 PM Indofarma cuts first quarter loss by 75%
10 August 2015 11:04 AM Indofarma Targets 15-20% Margin Growth yosefardi.biz
09 September 2015 04:43 PM Siti Fadilah testifies medical equipments case trial yosefardi.biz
A
Announcement
Indofarma (Persero) will hold annual shareholders meeting on April 19, 2018
2018-03-28 23:00:37
Links: [1] [2]
Trading suspension of Indofarma's stock has been lifted since December 27, 2017
2017-12-22 23:00:33
Links: [1] [2]
Stock trading suspension of Indofarma since December 22, 2017
2017-12-21 18:19:22
Links: [1] [2]
Indofarma (Persero) will hold annual shareholders meeting on April 20, 2017
2017-03-10 11:00:02
Links: [1] [2]
Indofarma will hold annual shareholders' meeting on April 6, 2016
2016-02-22 23:05:27
Links: [1] [2] [3] [4]
S
Financial
Period Revenue Net Profit
Q2 - 2018 270.338 M 8.738 M
Q1 - 2018 148.947 M -8.485 M
Q4 - 2017 854.971 M 17.865 M
Q3 - 2017 295.125 M -10.608 M
Q2 - 2017 273.309 M -18.708 M
Q1 - 2017 207.912 M -34.831 M
Q4 - 2016 806.075 M 13.041 M
Q3 - 2016 397.308 M -2.542 M
Full financial and operational data available to our premium users. Please check our premium data introduction page to learn more about our tools.
No prospectus found